Evidence map›Paper›PMID 36938858›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Engineering Escherichia coli to Utilize Erythritol as Sole Carbon Source.

Fang Ba, Xiangyang Ji, Shuhui Huang, Yufei Zhang, Wan-Qiu Liu, Yifan Liu, Shengjie Ling, Jian Li

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Two novel real-time PCR assays forMicrobiology spectrum · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Engineering Escherichia coli to Utilize Erythritol as Sole Carbon Source.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  6. Response of a new rumen-derivedFrontiers in microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Fang BaSchool of Physical Science and Technology, ShanghaiTech University, Shanghai, 201210, P. R. China.
Xiangyang JiSchool of Physical Science and Technology, ShanghaiTech University, Shanghai, 201210, P. R. China.
Shuhui HuangSchool of Physical Science and Technology, ShanghaiTech University, Shanghai, 201210, P. R. China.
Yufei ZhangSchool of Physical Science and Technology, ShanghaiTech University, Shanghai, 201210, P. R. China.
Wan-Qiu LiuSchool of Physical Science and Technology, ShanghaiTech University, Shanghai, 201210, P. R. China.
Yifan LiuSchool of Physical Science and Technology, ShanghaiTech University, Shanghai, 201210, P. R. China.
Shengjie LingSchool of Physical Science and Technology, ShanghaiTech University, Shanghai, 201210, P. R. China.
Jian LiSchool of Physical Science and Technology, ShanghaiTech University, Shanghai, 201210, P. R. China.ORCID 0000-0003-2359-238X
ShanghaiTech University · CN

Funding

National Natural Science Foundation of China 31971348National Natural Science Foundation of China 32171427ShanghaiTech University SYLDX0292022
6 · The paper itself

Abstract

Erythritol, one of the natural sugar alcohols, is widely used as a sugar substitute sweetener in food industries. Humans themselves are not able to catabolize erythritol and their gut microbes lack related catabolic pathways either to metabolize erythritol. Here, Escherichia coli (E. coli) is engineered to utilize erythritol as sole carbon source aiming for defined applications. First, the erythritol metabolic gene cluster is isolated and the erythritol-binding transcriptional repressor and its DNA-binding site are experimentally characterized. Transcriptome analysis suggests that carbohydrate metabolism-related genes in the engineered E. coli are overall upregulated. In particular, the enzymes of transaldolase (talA and talB) and transketolase (tktA and tktB) are notably overexpressed (e.g., the expression of tktB is improved by nearly sixfold). By overexpression of the four genes, cell growth can be increased as high as three times compared to the cell cultivation without overexpression. Finally, engineered E. coli strains can be used as a living detector to distinguish erythritol-containing soda soft drinks and can grow in the simulated intestinal fluid supplemented with erythritol. This work is expected to inspire the engineering of more hosts to respond and utilize erythritol for broad applications in metabolic engineering, synthetic biology, and biomedical engineering.

Indexed as

ErythritolEscherichia coliCarbonHumansMetabolic EngineeringTranscription FactorsCarbonErythritolTranscription Factorscarbon sourceerythritolEscherichia colimetabolic engineeringsynthetic biology

Identifiers

PMID36938858
PMCPMC10190533
OpenAlexW4327893916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.